Supplementary Materials
The percentages and absolute counts of B cells in RPs, TPs, and HIV-negative control groups at the baseline visit and the 12-month follow-up visit. HIV represents HIV-infected subjects, including RPs and TPs. HIV negative represents the HIV-negative control group. Comparisons of B-cell counts (a) and percentages (c) at the baseline visit were made among the different groups. Comparisons of B-cell counts (b) and percentages (d) at the 12-month follow-up visit were made among the different groups. P-values＜0.05 are considered statistically significant. The lines inside the boxes denote the medians.
Supplementary Fig 2: Comparisons between CD4
+ T-cell counts or HIV viral loads at the baseline visit and the 12-months follow-up visit in different groups based on the baseline B-cell counts. We grouped 45 HIV-infected subjects based on the absolute B-cell counts or percentages at the baseline visit. Subjects were put into the "B ＜ median" group when their absolute baseline B-cell counts were below the median (139 cells/μl). Alternatively, subjects were put into the "B ≥ median" group when their absolute baseline B-cell counts were above or equal to the median. Similarly, our study subjects were also grouped into the "B% ＜ median" group and the "B% ≥ median" group based on how subjects" baseline B-cell percentages were compared to the median (7%). Then we compared their CD4 + T-cell counts or HIV viral loads at the baseline visit (a, b) and the 12-months follow-up visit (c, d). P-values＜0.05 are considered statistically significant. The lines inside the boxes denote the medians. Supplementary Fig 3: Association between the baseline counts/percentages of CD8 + T-cells and HIV disease progression. CD8 + T-cell median counts and median percentages at the baseline visit were 1095 cells/μ l and 73%, respectively. According to these criteria, 23 subjects whose baseline CD8 + T-cell counts were above 1095 cells/μ l belonged to the "CD8 ≥ median" group, and 22 subjects whose baseline CD8 + T-cell counts were below 1095 cells/μ l belonged to the "CD8 ＜ median" group. Among these individuals, 24 subjects whose baseline CD8 + T-cell percentages were more than 73% were placed in the "CD8% ≥ median" group, and 21 subjects whose baseline CD8 + T-cell percentages were less than 73%
were placed in the "CD8% ＜ median" group. Correlations between CD8 + T-cells counts/percentages at baseline visit and CD4 + T-cell counts/viral loads at the 12-month follow-up visit. P-values＜0.05 are considered statistically significant. The lines inside the boxes denote the medians.
